Holen Sie sich die Stockscreener-App
122.10
5.96%
-7.74
Vorhandelsmarkt:
122.10
Schlusskurs vom Vortag:
$129.84
Offen:
$129.79
24-Stunden-Volumen:
386.98K
Relative Volume:
0.94
Marktkapitalisierung:
$2.04B
Einnahmen:
$5.82B
Nettoeinkommen (Verlust:
$-373.54M
KGV:
-5.4156
EPS:
-22.546
Netto-Cashflow:
$-87.01M
1W Leistung:
+5.39%
1M Leistung:
+7.29%
6M Leistung:
+400.05%
1J Leistung:
+130.38%
1-Tages-Spanne:
$116.00
$129.79
1-Wochen-Bereich:
$113.06
$133.04
52-Wochen-Spanne:
$7.48
$133.04
Agilon Health Inc Stock (AGL) Company Profile
Firmenname
Agilon Health Inc
Sektor
Branche
Telefon
562-256-3800
Adresse
440 POLARIS PARKWAY, WESTERVILLE
Compare AGL vs HCA, THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AGL
Agilon Health Inc
|
122.10 | 2.04B | 5.82B | -373.54M | -87.01M | -22.55 |
HCA
Hca Healthcare Inc
|
370.42 | 82.17B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
194.38 | 16.74B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
234.10 | 15.03B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
24.07 | 12.93B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
112.50 | 11.16B | 6.07B | 793.80M | 464.40M | 5.9914 |
Agilon Health Inc Stock (AGL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-20 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2025-08-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-25 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-04-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-10 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-01-10 | Eingeleitet | Needham | Hold |
| 2024-12-16 | Eingeleitet | Macquarie | Neutral |
| 2024-12-11 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-11-11 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-11-08 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-10-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-04-22 | Eingeleitet | Citigroup | Neutral |
| 2024-03-06 | Eingeleitet | Barclays | Underweight |
| 2024-02-26 | Herabstufung | Jefferies | Buy → Hold |
| 2024-02-26 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2024-01-08 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-01-08 | Herabstufung | Stifel | Buy → Hold |
| 2024-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-01-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-01-05 | Herabstufung | Truist | Buy → Hold |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-11-21 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-10-20 | Eingeleitet | The Benchmark Company | Buy |
| 2023-06-13 | Eingeleitet | Evercore ISI | In-line |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-09-14 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-09-12 | Eingeleitet | Goldman | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-06-24 | Eingeleitet | BTIG Research | Neutral |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-10-20 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-05-11 | Eingeleitet | William Blair | Outperform |
| 2021-05-10 | Eingeleitet | BofA Securities | Buy |
| 2021-05-10 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-10 | Eingeleitet | Goldman | Buy |
| 2021-05-10 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-10 | Eingeleitet | Truist | Buy |
| 2021-05-10 | Eingeleitet | Wells Fargo | Overweight |
| 2021-05-10 | Eingeleitet | Wolfe Research | Outperform |
Alle ansehen
Agilon Health Inc Aktie (AGL) Neueste Nachrichten
agilon health (AGL) Proxy filing Summary - Quartr
Timothy Patrick O'rourke Net Worth (2026) - GuruFocus
Why Is AGL Stock Rising Today? - Stocktwits
Wells Fargo Maintains Agilon Health(AGL.US) With Buy Rating, Maintains Target Price $141 - Moomoo
Agilon health stock hits 52-week high at 126.0 USD By Investing.com - Investing.com South Africa
Agilon health stock hits 52-week high at 126.0 USD - Investing.com
The Bull Case For agilon health (AGL) Could Change Following Strong 2024 REACH ACO Savings And Quality - Sahm
Price to book forward of agilon health, inc. – NYSE:AGL - TradingView
Price to book forward of agilon health, inc. – BOATS:AGL - TradingView
agilon health ACOs achieve $229M in savings under Medicare program - Investing.com India
AGL stock steadies as Agilon Health follows its care model - Ad-hoc-news.de
Brookdale Senior Q2'26 Sneak Peek: Occupancy Volume Rises to 82.4% - TradingView
agilon health ACOs achieve $229M in savings under Medicare program By Investing.com - Investing.com South Africa
agilon health Reports ACO REACH Model Results for 2024 Performance Year - Business Wire
Barclays Reaffirms Their Hold Rating on Agilon Health (AGL) - The Globe and Mail
Press Release: Agilon Health Sets Date to Report Second Quarter 2026 Financial Results - 富途牛牛
agilon health Sets Date to Report Second Quarter 2026 Financial Results - Business Wire
How Investors Are Reacting To agilon health (AGL) Scrutiny On Value-Based Medicare Advantage Execution - Yahoo Finance
Agilon Health stock stays tied to Medicare Advantage trends. - Ad-hoc-news.de
Deutsche Bank upgrades agilon health stock rating on raised guidance - Investing.com
Jefferies upgrades agilon health stock rating on rate visibility - Investing.com
AGL STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
Agilon Health (NYSE:AGL) Faces A Value Care Test - Kalkine Media
Form 4 agilon health Inc For: 2 July By Investing.com - Investing.com Nigeria
CFO of agilon health (AGL) uses 2,311 shares to cover RSU taxes - Stock Titan
Law Offices of Frank R. Cruz Encourages agilon health, inc. (AGL) - The National Law Review
AGL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review
AGL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
AGL Stockholders Have Opportunity to Lead agilon health, inc. Cla - The National Law Review
Price to sales forward of agilon health, inc. – NYSE:AGL - TradingView
3 Reasons AGL is Risky and 1 Stock to Buy Instead - Yahoo Finance
agilon health, inc. (AGL) Investigation: Bronstein, Gewirtz & Gro - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages agilon health, inc - The National Law Review
Enterprise value to EBITDA forward of agilon health, inc. – NYSE:AGL - TradingView
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
AGL Stock Jumps As agilon Health Ramps Market Outreach - timothysykes.com
Enterprise value to EBITDA forward of agilon health, inc. – BOATS:AGL - TradingView
Is the options market predicting a spike in Agilon Health stock? - MSN
AGL Jumps As agilon health Steps Up Outreach To Wall Street - StocksToTrade
AGL Stock Jumps As Traders Weigh Insider Moves And Conference Push - timothysykes.com
AGL Stock Climbs As agilon health Steps Up Outreach - StocksToTrade
AGL Jumps As agilon health Steps Up Conference Push - timothysykes.com
AGL Stock Rockets As Traders Focus On Conference Catalyst - StocksToTrade
Enterprise value to revenue forward of agilon health, inc. – NYSE:AGL - TradingView
Enterprise value to revenue forward of agilon health, inc. – BOATS:AGL - TradingView
Agilon Health (AGL) Is Up 0.79% in One Week: What You Should Know - Yahoo Finance
Why Fast-paced Mover Agilon (AGL) Is a Great Choice for Value Investors - Yahoo Finance
Enterprise value to EBIT forward of agilon health, inc. – BOATS:AGL - TradingView
1 Small-Cap Stock on Our Watchlist and 2 We Question - The Globe and Mail
Finanzdaten der Agilon Health Inc-Aktie (AGL)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.07%
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):